Evidence map›Paper›PMID 38773640›Full record

ArticleAlzheimer's research & therapy2024

Experimental colitis in young Tg2576 mice accelerates the onset of an Alzheimer's-like clinical phenotype.

Luca Lorenzini, Lorenzo Zanella, Michele Sannia, Vito Antonio Baldassarro, Marzia Moretti, Maura Cescatti, Corinne Quadalti, Simone Baldi, Gianluca Bartolucci, Leandro Di Gloria and 7 more

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Intestinal inflammation induces glymphatic remodeling, priming early neurodegenerative signals in male mice.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Luca Lorenzini *Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Bologna, Italy.
Lorenzo Zanella *Department of Veterinary Medical Sciences (DIMEVET), University of Bologna, Bologna, Italy.
Michele SanniaIRET Foundation, Bologna, Ozzano Emilia, Italy.
Vito Antonio BaldassarroDepartment of Veterinary Medical Sciences (DIMEVET), University of Bologna, Bologna, Italy.
Marzia MorettiDepartment of Veterinary Medical Sciences (DIMEVET), University of Bologna, Bologna, Italy.
Maura CescattiIRET Foundation, Bologna, Ozzano Emilia, Italy.
Corinne QuadaltiDepartment of Pharmacy and Biotechnology (FaBiT), University of Bologna, Via Tolara di Sopra 41/E, Bologna, 40064, Ozzano Emilia, Italy.
Simone BaldiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Gianluca BartolucciDepartment of Neuroscience, Psychology, Drug Research and Child Health NEUROFARBA, University of Florence, Florence, Italy.
Leandro Di GloriaDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.
Matteo RamazzottiDepartment of Biomedical, Experimental and Clinical Sciences "Mario Serio", University of Florence, Florence, Italy.
Paolo ClavenzaniDepartment of Veterinary Medical Sciences (DIMEVET), University of Bologna, Bologna, Italy.
Anna CostanziniDepartment of Translational Medicine, University of Ferrara, Ferrara, Italy.
Roberto De GiorgioDepartment of Translational Medicine, University of Ferrara, Ferrara, Italy.
Amedeo AmedeiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Laura CalzàDepartment of Pharmacy and Biotechnology (FaBiT), University of Bologna, Via Tolara di Sopra 41/E, Bologna, 40064, Ozzano Emilia, Italy. laura.calza@unibo.it.
Luciana GiardinoDepartment of Veterinary Medical Sciences (DIMEVET), University of Bologna, Bologna, Italy.

Funding

Fondazione Cassa di Risparmio in Bologna 20668Fondazione Maratona Alzheimer NAMinistero dell'Università e della Ricerca MNESYS (PE0000006)Università degli Studi di Ferrara FAR
6 · The paper itself

Abstract

Systemic inflammation and neuroinflammation affect the natural course of the sporadic form of Alzheimer's disease (AD), as supported by epidemiological and preclinical data, and several epidemiological studies indicate a higher prevalence of AD in patients with inflammatory bowel disease. In this study, we explored whether colitis induced by dextran sulfate sodium (DSS) in young, presymptomatic/preplaque mice worsens and/or anticipates age-dependent cognitive impairment in Tg2576, a widely used mouse model of AD. We demonstrated that DSS colitis induced in young Tg2576 mice anticipates the onset age of learning and memory deficit in the Morris water maze test. To explore potential mechanisms behind the acceleration of cognitive decline in Tg2576 mice by DSS colitis, we focused on gut microbiota, systemic inflammation and neuroinflammation markers. We observed a Firmicutes/Bacteroidetes ratio change in Tg2576 DSS animals comparable to that of elderly Tg2576 mice, suggesting accelerated microbiota aging in Tg2576 DSS mice, a change not observed in C57BL6 DSS mice. We also observed substantial differences between Tg2576 and WT mice in several inflammation and neuroinflammation-related parameters as early as 3 months of age, well before plaque deposition, a picture which evolved rapidly (between 3 and 5.5 months of age) in contrast to Tg2576 and WT littermates not treated with DSS. In detail, following induction of DSS colitis, WT and Tg2576 mice exhibited contrasting features in the expression level of inflammation-evoked astrocyte-associated genes in the hippocampus. No changes in microglial features occurred in the hippocampus between the experimental groups, whereas a reduced glial fibrillary acidic protein immunoreactivity was observed in Tg2576 vs. WT mice. This finding may reflect an atrophic, "loss-of-function" profile, further exacerbated by DSS where a decreased of GFAP mRNA expression level was detected. In conclusion, we suggest that as-yet unidentified peripheral mediators evoked by DSS colitis and involving the gut-brain axis emphasize an astrocyte "loss-of-function" profile present in young Tg2576 mice, leading to impaired synaptic morphological and functional integrity as a very early sign of AD.

Indexed as

Alzheimer DiseaseColitisDextran SulfateDisease Models, AnimalMice, Inbred C57BLMice, TransgenicAnimalsCognitive DysfunctionFemaleGastrointestinal MicrobiomeHippocampusMaleMicePhenotypeDextran SulfateAstrocytesCytokines/chemokinesGut microbiota/microbiomeNeuroinflammationPreclinical Alzheimer’s diseaseSystemic inflammationTg2576 mice

Identifiers

PMID38773640
PMCPMC11110243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.